SecBot SecBot
144 ·Filed Apr 29, 2026

WGSWW

GeneDx Holdings Corp.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001689575-26-000022
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine tax-motivated sale by an insider with no discretionary selling signal. Monitor for any unexpected acceleration of insider sales or changes in beneficial ownership filings, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled: T+20d
WGSWW ▲ 0.00% at T+20d
NEUTRAL call 0.00% · α vs SPY -5.23% · entry $0.007800 → $0.007800
Next anchor: T+60d due 3mo ago
Entry = T+0 close
Apr 29, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.22%
$0.007800
settled 6mo ago
T+5d
0.00%
call 0.00% · α -1.73%
$0.007800
settled 6mo ago
T+20d
0.00%
call 0.00% · α -5.23%
$0.007800
settled 5mo ago
T+60d
Pending
due 3mo ago

Price Chart

Loading chart...

Executive Summary

Director Katherine Stueland filed a Form 144 to sell 16,415 shares of Class A Common Stock valued at approximately $1.04 million, primarily to cover tax withholding obligations from vesting RSUs. The sale is a routine administrative action tied to equity compensation, not a discretionary insider liquidation.

Key Facts

  • Katherine Stueland, a Director and Officer, filed Form 144 to sell 16,415 shares of Class A Common Stock.
  • Estimated aggregate value of the proposed sale is approximately $1,037,500 based on a market price of $63.20 per share.
  • The sale is tied to vesting of restricted stock units (RSUs) on April 29, June 9, and June 16, 2026, primarily for tax withholding.
  • In the past 3 months, Stueland sold 94,902 shares to cover tax withholding on RSU vesting.
  • The filing is an advance notice of intent to sell; the actual sale may not occur.

Financial Impact

Approximately $1.04 million in shares proposed for sale, representing about 0.06% of total shares outstanding (based on 29,288,739 shares outstanding as of filing).

dilution

Risk Factors

  • If the company's stock price declines significantly before the sale, the insider may cancel the sale, but this is not a risk to the company.
  • No material risk to shareholders from this routine RSU-related sale.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Health Services

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001689575-26-000022
Document: 0001689575-26-000022-index.html0001689575-26-000022
Document: 0001689575-26-000022.txt0001689575-26-000022
2 reports for WGSWW
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for WGSWW, sortable and filterable
TypeNow
May 4, 2026
25w ago
8-K
BEARISH ★ 8/10
$0.007800 $0.007800· 0.00%▲ +4.95%No price
Apr 29, 2026
25w ago
144
NEUTRAL ★ 2/10
$0.007800 $0.007800· 0.00%▼ −5.23%No price
Showing 2 of 2

US Market Status

Market Closed · Opens in 2h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 29, 2026